Related Experiment Video
Updated: Jan 9, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Carisoprodol poisoning with serotonin toxicity
Conor Salmaan O'Flynn1, Shrey Singh2, Gim Tan2,3
1Emergency Department, The Alfred, Melbourne, Victoria, Australia c.oflynn@alfred.org.au.
Carisoprodol toxicity is rare but remains a drug of abuse. This case study reveals carisoprodol
Area of Science:
- Pharmacology
- Toxicology
- Neurology
Background:
- Carisoprodol is typically understood to act via GABA-A modulation.
- Despite regulations, carisoprodol remains a drug of abuse due to accessibility and cost.
- Previous reports have questioned the purely GABAergic mechanism of carisoprodol.
Purpose of the Study:
- To present a case of serotonin syndrome implicating carisoprodol.
- To highlight the potential serotonergic activity of carisoprodol.
- To challenge the established understanding of carisoprodol's mechanism of action.
Main Methods:
- Case report presentation.
- Clinical assessment of a patient presenting with specific symptoms.
- Review of carisoprodol's pharmacological profile and reported adverse events.
Main Results:
- A patient presented with symptoms consistent with serotonin syndrome.
- Carisoprodol was identified as a key agent in the patient's presentation.
- The findings suggest a potential serotonergic role for carisoprodol.
Conclusions:
- Carisoprodol may possess serotonergic activity.
- This activity contradicts the presumed GABAergic mechanism of carisoprodol.
- Further research is warranted to elucidate the full pharmacological profile of carisoprodol.
More Related Videos
10:08The Pilocarpine Model of Temporal Lobe Epilepsy and EEG Monitoring Using Radiotelemetry System in Mice
Published on: February 27, 2018
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Prevention of Further Absorption of Poison
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...